# 2025年12月6日 - 专业文献速递

本期速递为您整理了最新的科研文献及AI评价，每一篇文献都包含了详细的元数据、原文摘要、中文翻译和AI的专业点评，敬请参考。

---

## 1. 关于社区获得性肺炎的糖皮质激素务实性试验

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41159889)
**期刊：** The New England journal of medicine
**PMID：** 41159889
**DOI：** 10.1056/NEJMoa2507100

### 第一部分 原文与翻译

**英文原标题：** A Pragmatic Trial of Glucocorticoids for Community-Acquired Pneumonia.

> **英文摘要：**
> BACKGROUND: Adjunctive glucocorticoids may reduce mortality among patients with severe community-acquired pneumonia (CAP) in well-resourced settings. Whether these drugs are beneficial in low-resource settings with limited diagnostic and treatment facilities is unclear.
> 
> METHODS: In this pragmatic, open-label, randomized, controlled trial conducted in 18 public hospitals in Kenya, we assigned adult patients who had received a diagnosis of CAP and who did not have a clear indication for glucocorticoids to receive either standard care for CAP or oral low-dose glucocorticoids for 10 days in addition to standard care. The primary outcome was death from any cause at 30 days after enrollment.
> 
> RESULTS: A total of 2180 patients underwent randomization (1089 assigned to the glucocorticoid group and 1091 to the standard-care group). The median age of the patients was 53 years (interquartile range, 38 to 72); 46% were women. At day 30, deaths were reported in 530 patients (24.3%): 246 patients (22.6%) in the glucocorticoid group and 284 patients (26.0%) in the standard-care group (hazard ratio, 0.84; 95% confidence interval, 0.73 to 0.97; P = 0.02). The frequencies of adverse events and serious adverse events were similar in the two trial groups. Serious adverse events that were considered to be related to glucocorticoid administration occurred in 5 patients (0.5%).
> 
> CONCLUSIONS: In patients with CAP in a low-resource setting, adjunctive glucocorticoid therapy was associated with a lower risk of death than standard care. (Funded by Wellcome Trust and others; SONIA PACTR number, PACTR202111481740832; ISRCTN number, ISRCTN36138594.).

> **中文摘要：**
> 背景：在医疗资源充足的环境中，辅助使用糖皮质激素可能降低重度社区获得性肺炎（CAP）患者的死亡率。然而，在诊断与治疗设施有限的低资源环境中，这些药物是否同样具有益处尚不明确。
> 
> 方法：本研究为在肯尼亚18家公立医院开展的务实性、公开标签、随机对照试验。我们将已诊断为CAP但无明确糖皮质激素使用指征的成年患者，随机分配至接受CAP标准治疗或在标准治疗基础上口服低剂量糖皮质激素10天。主要结局指标为入组后30天内的全因死亡。
> 
> 结果：共2180名患者参与随机分组（1089例分配至糖皮质激素组，1091例分配至标准治疗组）。患者的中位年龄为53岁（四分位距38–72岁）；女性占46%。至第30天，共有530名患者（24.3%）死亡：糖皮质激素组246例（22.6%），标准治疗组284例（26.0%），风险比为0.84（95%置信区间0.73–0.97；P＝0.02）。两组的不良事件及严重不良事件发生频率相近。被认为与糖皮质激素使用相关的严重不良事件发生于5名患者（0.5%）。
> 
> 结论：在低资源环境下的CAP患者中，辅助糖皮质激素治疗较标准护理可降低死亡风险。（研究由Wellcome Trust等资助；SONIA PACTR注册号：PACTR202111481740832；ISRCTN注册号：ISRCTN36138594。）

### 第二部分 AI 大师评价

该研究采用务实性随机对照设计，评估在低资源环境中糖皮质激素用于社区获得性肺炎患者的死亡影响。结果显示，辅助糖皮质激素治疗明显降低了30天死亡率，且不增加严重不良事件风险。研究拓展了既往主要来自高收入地区证据的外延，具有重要的公共卫生意义。其局限在于开放标签设计可能带来一定偏倚，仍需进一步验证不同剂量及持续时间的最优方案。

---

## 2. 非洲肺炎的糖皮质激素治疗——旧疗法的新背景

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/41159881)
**期刊：** The New England journal of medicine
**PMID：** 41159881
**DOI：** 10.1056/NEJMe2514533

### 第一部分 原文与翻译

**英文原标题：** Glucocorticoids for Pneumonia in Africa - Old Therapy, New Context.

> **英文摘要：**
> No abstract available.

> **中文摘要：**
> 无可用摘要。

### 第二部分 AI 大师评价

本文可能是一篇社论或述评，探讨糖皮质激素在非洲地区用于肺炎治疗的潜在价值与挑战。该主题连接了经典抗炎治疗与资源有限环境下的公共卫生实际，强调了旧疗法在新流行病学与医疗体系背景中的再评估。文章的创新性在于提出区域特异性治疗考量，但受限于缺乏具体临床数据与方法描述，更多可能提供理论与策略层面的启发。

---

## 3. 通过人工智能驱动的分析表征支气管扩张症研究趋势

**原文链接：** [点击跳转](https://pubmed.ncbi.nlm.nih.gov/40876962)
**期刊：** The European respiratory journal
**PMID：** 40876962
**DOI：** 10.1183/13993003.00894-2025

### 第一部分 原文与翻译

**英文原标题：** Characterising research trends in bronchiectasis through AI-powered analytics.

> **英文摘要：**
> BACKGROUND: Interest in bronchiectasis is increasing and no prior study has used artificial intelligence (AI) to interrogate its rich, multidimensional literature to characterise research trends, themes and knowledge gaps.
> 
> METHODS: We reviewed original bronchiectasis research between 1949 and 2024 (a 75-year period) to identify, characterise and assess research trends and trajectories using two AI-powered approaches: 1) Atlas, an AI topic-modelling tool; and 2) a custom model, leveraging ChatGPT embedding and text generation models.
> 
> RESULTS: AI-powered analytics revealed a nine-fold increase in bronchiectasis research speed since 2000, typified by enhanced richness with four new research topics emerging every 5 years. Publication trends mirror clinical and technological advances, exemplified by significant rises in computed tomography, microbiome and clinical studies following the adoption of high-resolution computed tomography (1970s), next-generation sequencing (2005) and the first clinical guidelines (2008-2010), respectively. Topics with sustained growth ( popular topics) include bronchiectasis-COPD overlap, microbiome infection, cardiovascular health and exacerbations. Those with sudden, short-term increased interest ( trending topics) have focused on microbial pathogens and primary ciliary dyskinesia genetics. Mortality represents a nascent topic, demonstrating the highest year-on-year interest. Growth of research within the "vicious vortex" demonstrates thematic imbalance, with few studies overlapping with non-vortex components. Evolving research focus towards inflammation is evident, with increased work on comorbidities and quality of life demonstrating a shift from disease-centric to patient-centric research.
> 
> CONCLUSION: AI captures bronchiectasis as a dynamic and interdisciplinary field in continuing growth. Emerging research topics extend beyond the vicious vortex framework, indicating a transition from disease-centric to patient-centric approaches to optimise clinical care.

> **中文摘要：**
> 背景：对支气管扩张症的关注日益增加，但此前尚无研究利用人工智能（AI）对其丰富且多维的文献进行分析，以表征研究趋势、主题及知识空白。
> 
> 方法：我们回顾了1949年至2024年（共75年间）间的原创性支气管扩张症研究，采用两种AI驱动方法识别、表征并评估研究趋势及发展轨迹：（1）Atlas，一种基于AI的主题建模工具；（2）一种自定义模型，结合了ChatGPT的文本嵌入与生成模型。
> 
> 结果：AI驱动的分析显示，自2000年以来，支气管扩张症研究的速度增加了九倍，其丰富性显著提升，并且每5年约有4个新的研究主题出现。出版趋势反映了临床与技术的进步，例如随着高分辨率计算机断层扫描（20世纪70年代）、下一代测序技术（2005年）及首部临床指南（2008–2010年）的引入，计算机断层扫描、微生物组及临床研究显著增长。持续增长的研究主题（热门主题）包括支气管扩张症与慢性阻塞性肺疾病重叠、微生物组感染、心血管健康及急性加重。而出现短期突增兴趣的研究主题（趋势主题）主要聚焦于微生物病原体及原发性纤毛运动障碍的遗传学。死亡率研究为新兴主题，显示出年度兴趣增幅最高。“恶性循环”框架内研究的增长呈现主题不平衡，极少有研究与非循环成分重叠。研究焦点正逐渐转向炎症领域，且对合并症与生活质量的关注增加，显示出研究正从“疾病中心”向“以患者为中心”转变。
> 
> 结论：AI揭示支气管扩张症是一个持续增长、动态且跨学科的研究领域。新兴研究主题正在突破传统“恶性循环”框架，表明研究正从以疾病为核心向以患者为核心的方向转变，以优化临床照护。

### 第二部分 AI 大师评价

本研究首次利用人工智能解析支气管扩张症领域的长期学术文献，系统揭示了其研究增长轨迹与热点演变。通过主题建模与生成模型结合的方法，研究描绘了自2000年以来学术产出与主题多样性的显著提升。结果指出，研究焦点正从“疾病机制”逐渐转向“患者体验与生活质量”，体现了理念上的转型。创新之处在于以AI大规模文本挖掘方法描摹科研生态；然而，模型依赖文献质量与语义算法的局限，仍需在临床验证上进一步平衡。

---

速递结束，祝您工作愉快！